Skip to content

Clinical trials

Phase 2 Xerostomia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Xerostomia Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20062
20081
20092
20111
20191
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Dental and Craniofacial Research (NIDCR)5
Dana-Farber Cancer Institute1
Institut de Recherches Internationales Servier1
Masonic Cancer Center, University of Minnesota1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Parion Sciences1
Radiation Therapy Oncology Group1
Roswell Park Cancer Institute1
TorreyPines Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Xerostomia15
Sjogren's Syndrome9
Autoimmune Diseases5
Squamous Cell Carcinoma of Head and Neck5
Head and Neck Neoplasms4
Mucositis4
Radiation Injuries4
Salivary Gland Diseases4
Arthritis2
Dry Eye Syndromes2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.